These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29801021)

  • 1. Prostate Cancer Screening-A New Recommendation for Meaningful Physician-Patient Conversations.
    Misra-Hebert AD; Kattan MW
    JAMA Oncol; 2018 Aug; 4(8):1049-1050. PubMed ID: 29801021
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline.
    Tikkinen KAO; Dahm P; Lytvyn L; Heen AF; Vernooij RWM; Siemieniuk RAC; Wheeler R; Vaughan B; Fobuzi AC; Blanker MH; Junod N; Sommer J; Stirnemann J; Yoshimura M; Auer R; MacDonald H; Guyatt G; Vandvik PO; Agoritsas T
    BMJ; 2018 Sep; 362():k3581. PubMed ID: 30185545
    [No Abstract]   [Full Text] [Related]  

  • 3. The influence of physician recommendation on prostate-specific antigen screening.
    Pucheril D; Dalela D; Sammon J; Sood A; Sun M; Trinh QD; Menon M; Abdollah F
    Urol Oncol; 2015 Oct; 33(10):424.e1-7. PubMed ID: 26206103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Navigating Prostate Cancer Screening in the Real World of Primary Care: The Mirage and the Quicksand.
    Mathew P; Hachem H; Han P
    JAMA Oncol; 2018 Apr; 4(4):453-454. PubMed ID: 29470576
    [No Abstract]   [Full Text] [Related]  

  • 5. [Give itself the ways to listen to a different voice].
    Bungener M
    Med Sci (Paris); 2017 Apr; 33(4):371-372. PubMed ID: 28497728
    [No Abstract]   [Full Text] [Related]  

  • 6. Urologists' Current Practices in Screening and Treating Men With a Family History of Prostate Cancer.
    Rudichuk L; Vogel KJ; Wang CH; Helfand BT; Selkirk CG
    Urology; 2017 Jan; 99():180-185. PubMed ID: 27645528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A longitudinal study of changes in provider-patient interaction in treatment of localized prostate cancer.
    Ernstmann N; Ommen O; Kowalski C; Neumann M; Visser A; Pfaff H; Weissbach L
    Support Care Cancer; 2012 Apr; 20(4):791-7. PubMed ID: 21479989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of an International Consensus Conference on Practice Patterns in Advanced Prostate Cancer.
    Gong J; Omlin A; Pal SK; Hsu J; Tombal B; Sydes MR; Gillessen S
    Eur Urol; 2018 Aug; 74(2):239-240. PubMed ID: 29731257
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostate biopsy: will transperineal replace transrectal?
    Acher P; Dooldeniya M
    BJU Int; 2013 Sep; 112(5):533-4. PubMed ID: 23924418
    [No Abstract]   [Full Text] [Related]  

  • 10. Physicians' Perceptions of Factors Influencing the Treatment Decision-making Process for Men With Low-risk Prostate Cancer.
    Davis K; Bellini P; Hagerman C; Zinar R; Leigh D; Hoffman R; Aaronson D; Van Den Eeden S; Philips G; Taylor K
    Urology; 2017 Sep; 107():86-95. PubMed ID: 28454988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PSA testing for men at average risk of prostate cancer.
    Armstrong BK; Barry MJ; Frydenberg M; Gardiner RA; Haines I; Carter SM
    Public Health Res Pract; 2017 Jul; 27(3):. PubMed ID: 28765854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physician behaviors to promote informed decisions for prostate cancer screening: a National Research Network study.
    Linder SK; Kallen MA; Mullen PD; Galliher JM; Swank PR; Chan EC; Volk RJ
    J Cancer Educ; 2014 Jun; 29(2):345-9. PubMed ID: 24488590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing primary care physicians' decision to order prostate-specific antigen (PSA) test for men without prostate cancer.
    Hayat Roshanai A; Nordin K; Berglund G
    Acta Oncol; 2013 Nov; 52(8):1602-8. PubMed ID: 23421929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prostate cancer screening using prostate-specific antigen: The views of general and laboratory physicians].
    Giménez N; Filella X; Gavagnach M; Allué JA; Pedrazas D; Ferrer F;
    Semergen; 2018 Sep; 44(6):409-419. PubMed ID: 29574008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relevance of total PSA and free PSA prescriptions.
    Lamy PJ; Brouillet JP; Bermont L; Fouillet G; Loric S
    Ann Biol Clin (Paris); 2018 Dec; 76(6):659-663. PubMed ID: 30543191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do men with lower urinary tract symptoms have an increased risk of advanced prostate cancer?
    Østerø Í Jákupsstovu J; Brodersen J
    BMJ; 2018 May; 361():k1202. PubMed ID: 29724877
    [No Abstract]   [Full Text] [Related]  

  • 17. Primary Care Physicians Beliefs about Prostate-Specific Antigen Evidence Uncertainty, Screening Efficacy, and Test Use.
    Ross LE; Hall IJ; Howard DL; Rim SH; Richardson LC
    J Natl Med Assoc; 2018 Oct; 110(5):491-500. PubMed ID: 30129508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary care perspective and implementation of a multidisciplinary, institutional prostate cancer screening algorithm embedded in the electronic health record.
    Aminsharifi A; Schulman A; Anderson J; Fish L; Oeffinger K; Shah K; Sze C; Tay KJ; Tsivian E; Polascik TJ
    Urol Oncol; 2018 Nov; 36(11):502.e1-502.e6. PubMed ID: 30170982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decision Making in Oncology.
    Putora PM
    JCO Clin Cancer Inform; 2019 Feb; 3():1-2. PubMed ID: 30730763
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostate cancer screening in New Zealand.
    Gray B
    N Z Med J; 2013 Sep; 126(1383):94. PubMed ID: 24157998
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.